Inhibrx Chief Medical Officer Klaus Wagner's 2020 pay jumps 89% to $977K
Inhibrx reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Inhibrx reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, four Inhibrx executives received on average a compensation package of $754K, a 10% increase compared to previous year.
Average pay of disclosed executives at Inhibrx
Klaus W. Wagner, Chief Medical Officer, received $977K in total, which increased by 89% compared to 2019. 41% of Wagner's compensation, or $396K, was in salary. Wagner also received $198K in non-equity incentive plan, $377K in option awards, as well as $6K in other compensation.
Mark P. Lappe, Chief Executive Officer, received a compensation package of $869K, which increased by 1% compared to previous year. 61% of the compensation package, or $530K, was in salary.
Brendan P. Eckelman, Chief Scientific Officer, earned $590K in 2020, a 13% decrease compared to previous year.
Kelly D. Deck, Chief Financial Officer, received $580K in 2020.
Related executives
You may also like
Source: SEC filing on April 28, 2021.